Simrat Randhawa
Vermogen: 427 680 $ op 31-07-2026
Vermogen: 427 680 $ op 31-07-2026
Simrat Randhawa is currently Executive VP, Head-Research & Development at Dianthus Therapeutics, Inc. since 2023.
Former positions include Senior Vice President-Clinical & Medical Affairs at Aurinia Pharmaceuticals, Inc. from 2019 to 2022, and Head-Medical Affairs at BioMarin Pharmaceutical, Inc. Education includes an MBA from The Trustees of Columbia University in The City of New York and a doctorate from Drexel University College of Medicine.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-06-2026 | 4.000 ( 0,01% ) | 427 680 $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 11-09-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Hoofd Techniek/Wetenschap/O&O | 01-04-2022 |
| BIOMARIN PHARMACEUTICAL INC. | Hoofd Techniek/Wetenschap/O&O | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
BioMarin Pharmaceutical, Inc.
BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Drexel University College of Medicine
Drexel University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aurinia Pharmaceuticals, Inc.
Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Dianthus Therapeutics, Inc.
Dianthus Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for patients with autoimmune and inflammatory diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau